Curaleaf Holdings, Inc. has announced a significant expansion of its Florida operations with the grand opening of a new medical cannabis dispensary in St. Augustine. The new location, which officially opened its doors on August 1, 2025, represents Curaleaf’s 68th store within the Sunshine State and its 154th location nationwide. This strategic expansion underscores the company’s commitment to increasing patient access to high-quality medical cannabis products across key markets.
Comprehensive Product Portfolio Now Available
The St. Augustine dispensary offers a wide array of medical cannabis products designed to meet diverse patient needs. Consumers can expect to find Curaleaf’s newly launched Grassroots Dark Heart Collection, a testament to the company’s focus on premium offerings. Additionally, the store features popular Select brand vapes and edibles, known for their consistent quality and efficacy. A key highlight for Florida patients is the availability of the Florida-exclusive flower brand, Reef, alongside Anthem pre-rolls, further diversifying the product selection.
A Leap Forward in Cannabis Flower Quality
Chairman and CEO Boris Jordan emphasized the company’s dedication to driving innovation within the cannabis sector, particularly concerning flower quality. He highlighted recent advancements across Curaleaf’s proprietary brands, specifically mentioning new flower strains from Reef, Grassroots, and Anthem. Jordan described these new flower products as surpassing anything previously encountered in the Florida market, setting a new benchmark for the state’s medical cannabis industry. This focus on superior cultivation and genetics aims to provide patients with an elevated experience.
Commitment to Craft Quality at Scale
Jordan further elaborated on Curaleaf’s overarching strategy, stating the company’s unwavering commitment to producing craft quality flower at scale. This ambitious goal is supported by a robust operational framework and a customer-centric approach, including a no-risk guarantee on its products. This guarantee reflects confidence in the quality and consistency of Curaleaf’s offerings, aiming to build trust and ensure patient satisfaction. The expansion into St. Augustine is directly linked to this commitment, designed to bring these enhanced products and the company’s quality promise to a broader patient base.
The introduction of the St. Augustine dispensary is more than just an increase in retail locations; it signifies Curaleaf’s proactive approach to meeting the growing demand for sophisticated and high-quality cannabis products in Florida. By broadening patient access to their innovative brands and ensuring a high standard of product quality, Curaleaf aims to solidify its position as a leader in the medical cannabis market. The company’s investment in new product launches and brand development, as exemplified by the new flower collections and the continued success of brands like Select and Reef, demonstrates a forward-thinking strategy focused on patient well-being and market leadership.
